A Multicenter, Randomized, Parallel Group, Double-Blind, Multiple Dose, Placebo-Controlled Study to Assess the Efficacy and Safety of MNK-1411 in Male Subjects 4 to 8 Years of Age With Duchenne Muscular Dystrophy
Brave Trial, A Clinical Research Study for Duchenne Muscular Dystrophy (DMD)
Sponsor: Mallinckrodt
Enrolling: Male Patients Only
Study Length: 14 Months
IRB Number: AAAR7151
U.S. Govt. ID: NCT03400852
Contact: Ameneh Onativia: 212-342-3679 / am2959@cumc.columbia.edu
Additional Study Information: Our clinic is currently participating in the Brave Trial, a clinical research study for Duchenne muscular dystrophy (DMD). This study is being conducted to learn whether a study drug can improve motor functions in boys with DMD. If your child takes part, he'll receive at no cost: study drug or placebo, study-related procedures, reimbursement for reasonable expenses.
This study is closed
Investigator
Darryl De Vivo, MD
Do You Qualify?
Has the patient been diagnosed with Duchenne muscular dystrophy? Yes No
Is the patient a male? Yes No
Is he at least 4 years old? Yes No
Is he younger than 9 years old? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder


CAPTCHA
Image CAPTCHA
Enter the characters shown in the image.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Cancel
For more information, please contact:
Ameneh Onativia
am2959@cumc.columbia.edu
212-342-3679
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE